A previous study suggested elevated GRP78/BiP level as a significant factor for predicting a favorable prognosis in patients with lung cancer [28], whereas a review indicated that elevated GRP78/BiP level correlated with drug resistance, tumor recurrence, and poor survival [23]. Here, HSPA5 is linked to lung cancer.